cytarabine and Cancer of Ovary

cytarabine has been researched along with Cancer of Ovary in 77 studies

Research

Studies (77)

Timeframe	Studies, this research(%)	All Research%
pre-1990	40 (51.95)	18.7374
1990's	25 (32.47)	18.2507
2000's	7 (9.09)	29.6817
2010's	4 (5.19)	24.3611
2020's	1 (1.30)	2.80

Authors

Authors	Studies
Ajisaka, K; Fujimoto, H; Takayanagi, T	1
Dimas, K; Eleutheriades, A; Foscolos, GB; Georgakopoulou, S; Khan, H; Kourafalos, VN; Mantelas, A; Mirjolet, JF; Moutsos, VI; Papanastasiou, I; Pondiki, S; Prassa, M; Riganas, S; Serin, G; Theodoropoulou, M; Tsotinis, A; Vamvakides, A; Zaniou, A	1
Islam, S; Pal, S; Santra, MK; Sivakrishna, B	1
Choi, JY; Kang, MG; Kim, HY; Lee, WS; Shin, JK; Song, HN	1
Chen, Y; Cheng, N; Jiang, Y; Liu, X; Nowak, B; Plunkett, W; Qiang, B	1
Aamdal, S; Dueland, S; Gaullier, JM; Lind, MJ; Rasch, W; Sandvold, ML; Thomas, H	1
Amant, F; Breda, E; Cannella, L; Hernes, K; Leunen, K; Lorusso, D; Pignata, S; Pisano, C; Rasch, W; Scambia, G; Sorio, R; Vergote, I	1
Bjornsti, MA; de Jong, LA; Jansen, LE; Pluim, D; Schellens, JH; van Eijndhoven, MA; van Waardenburg, RC; Verseyden, C	1
Bauman, J; Biroc, SL; Chesney, SK; Dinter, H; Ho, E; Hoffmann, J; Kirkland, T; Liu, HL; Shen, J; Subramanyam, B; Tseng, JL; Zajchowski, DA	1
Magri, K; Maillet, R; Riethmuller, D	1
Lilleyman, JS; Wyld, PJ	1
Green, MR; Howell, SB; Lucas, WE; Markman, M; Pfeifle, CE	1
Howell, SB; King, ME; Pfeifle, CE	1
Hanyu, T; Higashiiwai, H; Igarashi, N; Kinii, H; Mori, T; Moritsuka, T; Nagasawa, K; Nakano, M; Sato, A; Sato, S; Suzuki, K; Suzuki, M; Watanabe, M; Yajima, A	1
Mori, T; Sakahira, H; Sato, S; Suzuki, M; Wakisaka, T; Yajima, A; Yamauchi, R	1
Averette, HE; Jobson, VW; Nordqvist, SR	1
Balconi, G; D'Incalci, M; Erba, E; Garattini, S; Morasca, L; Ottolenghi, L; Salmona, A	1
Monaghan, P; Peckham, MJ; Selby, PJ; Sloane, J; Thomas, JM	1
Baker, TR; Driscoll, D; Piver, MS; Recio, FO	1
Lin, JY; Scheim, DE	1
Inoue, T; Ishihara, T; Ishii, E; Koga, H; Matsuzaki, A; Miyazaki, S; Nibu, K; Take, H; Ueda, K; Yanai, F	1
Chorvath, B; Duraj, J; Hunakova, L; Novotny, L; Sedlak, J	1
Arii, Y; Hattori, S; Kawai, M; Kikkawa, F; Ohta, M; Tomoda, Y	1
Brunetti, I; Bruzzone, M; Conte, PF; Fioretti, P; Gadducci, A; Ragni, N	1
Dyson, PG; Juttner, CA; Roberts, MM; To, LB; Willson, K	1
Barakat, RR; Brown, C; Curtin, JP; Fennelly, D; Pizzuto, F; Venkatraman, ES	1
Driscoll, DL; Hempling, RE; Piver, MS; Recio, FO	1
Campbell, LJ; Ellims, PH; Estey, EH; Juneja, SK; Prince, HM; Seymour, JF	1
Ling, V; Zhang, W	1
Fujii, S; Fukushi, Y; Futagami, M; Higuchi, T; Saito, Y; Sakamoto, T; Sato, S; Takami, H; Yokoyama, Y	1
Chithrathara, K; Elizabath, KA; Gangadharan, VP; Preetha, S; Sreejith, G	1
Mathews, CK	1
Bungay, PM; Dedrick, RL; DeVita, VT; Myers, CE	1
Burchenal, J; D'angio, G; Exelby, P; Fang, S; Lieberman, P; Murphy, ML; Wollner, N	1
Cady, J; de Gramont, A; Demuynck, B; Gonzalez-Canali, G; Herbulot, P; Lagadec, B; Louvet, C; Marpeau, L; Pigné, A; Varette, C	2
Hempling, RE; Piver, MS; Sprance, HE	1
Bhalla, K; Bullock, G; Holladay, C; Ibrado, AM; Jasiok, M; Lutzky, J; Singh, S	1
Almadrones, L; Barakat, R; Curtin, J; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S	1
Frankfurt, OS	1
Almadrones, L; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S	1
Almadrones, L; Eriksson, J; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S; Yordan, EL	1
Durosinmi, MA; Lawal, OO; Ojo, OS	1
Cleary, SM; Howell, SB; Kirmani, S; Mowry, J; Zimm, S	1
Alama, A; Bruzzone, M; Campora, E; Carnino, F; Chiara, S; Foglia, G; Iskra, L; Parodi, S; Ragni, N; Rosso, R	1
Gitsch, E; Salzer, H; Schmidl, S; Sevelda, P	1
Averette, HE; Boike, G; Nguyen, H; Perras, J; Petru, E; Ramos, R; Sevin, BU	1
Adachi, S; Hirooka, C; Ichijo, M; Kiyozuka, Y; Noda, T; Oku, M; Yamamoto, T	1
Markman, M	4
Ikeuchi, H; Inoue, H; Kohno, M; Matsunaga, S; Miyake, H; Nishiyama, S; Sekigawa, S; Tanaka, Y; Tanizawa, O; Ueda, G	1
Cleary, S; Howell, SB; Lucas, W; Markman, M; Weiss, R	1
Bagshawe, KD; Begent, RH; Newlands, ES; Pektasides, D; Rustin, GJ	2
Abramson, IS; Cleary, S; Howell, SB; Lucas, WE; Markman, M; Weiss, RJ; Zimm, S	1
Lele, SB; Matharu, J; Piver, MS; Tsukada, Y	1
Arii, Y; Imaizumi, H; Inagaki, S; Kakihara, M; Kawai, M; Yamashita, H	1
Bianco, AR; De Placido, G; De Placido, S; Frasci, G; Iaffaioli, RV; Lombardi, D; Mastrantonio, P; Montemagno, U; Palmieri, G	1
Kano, T; Ohta, M; Tomoda, Y	1
Berek, JS; Knox, RM; Schink, JC	1
Bertoncello, I; Bradley, TR; Jamieson, GP; Snook, MB; Wiley, JS	1
Averette, HE; Donato, D; Jarrell, MA; Kingston, RE; Ramos, R; Saks, M; Sevin, BU	1
Adachi, S; Akada, S; Ichijo, M; Kiyozuka, Y; Maruyama, M; Noda, T; Okamura, Y; Oku, M	1
Cashavelly, B; Fuller, AF; Lind, SE	1
Howell, SB; Markman, M	1
Courter, SG; Dunn, MP; Krzeczowski, KA	1
Olson, EZ; Selders, NJ	1
Cleary, S; Howell, SB; Lucas, WE; Markman, M	1
Alberts, DS; Mason, N; Salmon, SE; Young, L	1
Gill, S; Howell, SB	1
Arii, Y; Casanova, H; Kano, T; Kazato, S; Miyazaki, T; Nishida, Y; Ohta, M; Sakakibara, K; Tomoda, Y; Umemura, S	1
Mattern, J; Volm, M; Wayss, K	1
Hsu, KP; Li, MC	1
Cohen, SM; Greenspan, EM; Weiner, MJ	1
Clarkson, BD; Fried, J; Sheehy, PF; Winn, R	1

Reviews

6 review(s) available for cytarabine and Cancer of Ovary

Article	Year
Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy. Leukemia, 1999, Volume: 13, Issue:11 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Prognosis; Treatment Outcome	1999
Intracavitary chemotherapy. Critical reviews in oncology/hematology, 1985, Volume: 3, Issue:3 Topics: Absorption; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Bacterial Infections; Bleomycin; Cisplatin; Cytarabine; Diffusion; Doxorubicin; Drug Synergism; Female; Fluorouracil; Humans; Immunotherapy; Melphalan; Methotrexate; Mitomycins; Neoplasms; Ovarian Neoplasms; Peritoneal Cavity; Permeability; Pleura; Pleural Effusion; Radiation-Sensitizing Agents; Sclerosis; Streptozocin	1985
Peritoneal papillary carcinoma. Gynecologic oncology, 1988, Volume: 31, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Papillary; Child; Cisplatin; Cytarabine; Female; Humans; Middle Aged; Neoplasm Invasiveness; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies	1988
Cytotoxic intracavitary chemotherapy. The American journal of the medical sciences, 1986, Volume: 291, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Catheterization; Cisplatin; Clinical Trials as Topic; Colonic Neoplasms; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Liver Circulation; Liver Neoplasms; Ovarian Neoplasms; Pleural Neoplasms	1986
The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trials. Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3 Topics: Abdomen; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Female; Humans; Kidney Diseases; Kinetics; Leukopenia; Nausea; Neoplasms; Ovarian Neoplasms; Pain; Peritoneal Cavity; Peritonitis; Pleura; Thrombocytopenia; Vomiting	1985
Combined drug therapy for ovarian carcinoma. Clinical obstetrics and gynecology, 1970, Volume: 13, Issue:4 Topics: Antineoplastic Agents; Carcinoma; Cell Division; Cobalt Isotopes; Cytarabine; DNA, Neoplasm; Drug Synergism; Female; Humans; Neoplasms, Germ Cell and Embryonal; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prednisone; Radioisotope Teletherapy	1970

Trials

13 trial(s) available for cytarabine and Cancer of Ovary

Article	Year
Intravenous administration of CP-4055 (ELACYT) in patients with solid tumours. A Phase I study. Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Melanoma; Middle Aged; Neoplasms; Ovarian Neoplasms	2009
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:5 Topics: Antimetabolites, Antineoplastic; Cytarabine; Female; Humans; Middle Aged; Ovarian Neoplasms	2011
Glucose effects in an ovarian cancer protocol of exceptional activity. Medical hypotheses, 1993, Volume: 40, Issue:4 Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cytarabine; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Glucose; Humans; Ifosfamide; Infusions, Parenteral; Injections, Intravenous; Middle Aged; Models, Biological; Neoplasm Staging; Ovarian Neoplasms; Reoperation; Thiosulfates	1993
[Extramedullary relapse in childhood acute lymphoblastic leukemia: experience at the Kyushu Yamaguchi Children's Cancer Study Group]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:2 Topics: Adolescent; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Male; Methotrexate; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Testicular Neoplasms	1995
Therapeutic experience of the North-West Oncology Group (GONO) on ovarian carcinoma. European journal of gynaecological oncology, 1994, Volume: 15, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Italy; Neoplasm, Residual; Ovarian Neoplasms; Pilot Projects; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction	1994
Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseases. Bone marrow transplantation, 1996, Volume: 18, Issue:1 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Cell Differentiation; Cell Lineage; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Megakaryocytes; Multiple Myeloma; Ovarian Neoplasms; Platelet Count; Thioguanine; Time Factors	1996
Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced ovarian cancer. Gynecologic oncology, 1998, Volume: 68, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cytarabine; Disease-Free Survival; Female; Humans; Infusions, Parenteral; Middle Aged; Multivariate Analysis; Ovarian Neoplasms; Prospective Studies	1998
Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Neoplasm Recurrence, Local; Ovarian Neoplasms; Retrospective Studies	1991
Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Parenteral; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remission Induction; Survival Rate	1991
Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin. Cancer treatment reports, 1986, Volume: 70, Issue:6 Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheters, Indwelling; Cisplatin; Clinical Trials as Topic; Cytarabine; Drug Administration Schedule; Female; Humans; Injections, Intraperitoneal; Laparotomy; Male; Middle Aged; Ovarian Neoplasms; Pain; Peritoneal Cavity; Solutions; Vomiting	1986
The adjuvant treatment of ovarian cancer: result of the pilot study of a new combination chemotherapeutic regimen (DAC). European journal of gynaecological oncology, 1989, Volume: 10, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Female; Humans; Ovarian Neoplasms; Pilot Projects	1989
Cytotoxic intracavitary chemotherapy. The American journal of the medical sciences, 1986, Volume: 291, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Catheterization; Cisplatin; Clinical Trials as Topic; Colonic Neoplasms; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Liver Circulation; Liver Neoplasms; Ovarian Neoplasms; Pleural Neoplasms	1986
Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Catheters, Indwelling; Cisplatin; Clinical Trials as Topic; Cytarabine; Female; Humans; Male; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity; Peritoneal Neoplasms; Time Factors	1985

Other Studies

59 other study(ies) available for cytarabine and Cancer of Ovary

Article	Year
Synthesis of N-acetylglucosamine-modified ara-C and its effect on ovarian cancer cells. Journal of medicinal chemistry, 1994, Oct-14, Volume: 37, Issue:21 Topics: Antineoplastic Agents; Bacillus; Cell Division; Chitinases; Chromatography, High Pressure Liquid; Cytarabine; Female; Glycosylation; Humans; Molecular Structure; Ovarian Neoplasms; Tumor Cells, Cultured	1994
New adamantane phenylalkylamines with σ-receptor binding affinity and anticancer activity, associated with putative antagonism of neuropathic pain. Journal of medicinal chemistry, 2012, Nov-26, Volume: 55, Issue:22 Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Proliferation; Female; Humans; Male; Mice; Mice, SCID; Molecular Structure; Neuralgia; Ovarian Neoplasms; Pancreatic Neoplasms; Piperidines; Prostatic Neoplasms; Protein Binding; Receptors, sigma; Structure-Activity Relationship; Tumor Cells, Cultured	2012
Synthesis and cytotoxic evaluation of apioarabinofuranosyl pyrimidines. Drug development research, 2020, Volume: 81, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Cytarabine; Female; Humans; MCF-7 Cells; Ovarian Neoplasms; Pyrimidines; Structure-Activity Relationship	2020
Bilateral ovarian granulocytic sarcoma as the primary manifestation of acute myelogenous leukemia treated with allogenic stem cell transplantation: A case report. Medicine, 2019, Volume: 98, Issue:52 Topics: Adult; Antimetabolites, Antineoplastic; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Ovarian Neoplasms; Sarcoma, Myeloid; Stem Cell Transplantation	2019
Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations. Cancer chemotherapy and pharmacology, 2018, Volume: 81, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Chromosome Aberrations; Cytarabine; DNA Damage; Drug Synergism; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Poly (ADP-Ribose) Polymerase-1; Tumor Stem Cell Assay	2018
Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin. The Journal of biological chemistry, 2004, Dec-24, Volume: 279, Issue:52 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cisplatin; Colonic Neoplasms; Cytarabine; DNA; DNA Adducts; DNA Topoisomerases, Type I; Drug Synergism; Enzyme Inhibitors; Female; Humans; Models, Molecular; Ovarian Neoplasms; Platinum Compounds; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured	2004
Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models. International journal of cancer, 2005, May-10, Volume: 114, Issue:6 Topics: Animals; Carcinoma; Cytarabine; Disease Models, Animal; Female; Mice; Mice, Nude; Ovarian Neoplasms; Pancreatic Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured	2005
[Pelvic Burkitt lymphoma mimicking an ovarian tumor]. Journal de gynecologie, obstetrique et biologie de la reproduction, 2006, Volume: 35, Issue:3 Topics: Adult; Antimetabolites, Antineoplastic; Burkitt Lymphoma; Cytarabine; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Ovarian Neoplasms; Pelvic Pain; Treatment Outcome	2006
Ovarian disease in childhood lymphoblastic leukaemia. Acta haematologica, 1983, Volume: 69, Issue:4 Topics: Brain Neoplasms; Child, Preschool; Cytarabine; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Methotrexate; Ovarian Neoplasms	1983
Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Doxorubicin; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms	1984
Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:6 Topics: Adult; Aged; Arabinofuranosyluracil; Cytarabine; Female; Humans; Injections, Intraperitoneal; Kinetics; Middle Aged; Ovarian Neoplasms; Peritoneal Dialysis; Tumor Stem Cell Assay	1984
Combination chemotherapy in advanced ovarian cancer. The Tohoku journal of experimental medicine, 1980, Volume: 132, Issue:2 Topics: Antineoplastic Agents; Carbazilquinone; Cytarabine; Drug Therapy, Combination; Female; Humans; Ovarian Neoplasms; Tegafur	1980
FQC combination chemotherapy for primary malignant ovarian tumor. Gynecologic oncology, 1982, Volume: 13, Issue:1 Topics: Azirines; Carbazilquinone; Cytarabine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Ovarian Neoplasms; Tegafur	1982
Advanced and recurrent carcinoma of the ovary treated with a combination of cyclophosphamide, doxorubicin, and cytosine arabinoside. Gynecologic oncology, 1983, Volume: 15, Issue:2 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms	1983
Pharmacokinetic approach to in vitro testing of ovarian cancer cell sensitivity. Oncology, 1980, Volume: 37, Issue:3 Topics: Antineoplastic Agents; Cell Survival; Cytarabine; Dactinomycin; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance; Female; Fluorouracil; Half-Life; Humans; In Vitro Techniques; Melphalan; Methotrexate; Ovarian Neoplasms	1980
Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. British journal of cancer, 1980, Volume: 41, Issue:1 Topics: Animals; Cytarabine; Female; Humans; Immunosuppression Therapy; Karyotyping; Male; Melanoma; Mice; Mice, Inbred CBA; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Radiation Effects; Thymectomy; Time Factors; Transplantation, Heterologous; Uterine Neoplasms	1980
Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer. Cancer, 1994, Mar-15, Volume: 73, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Protocols; Cystadenocarcinoma, Serous; Cytarabine; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Laparotomy; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Remission Induction; Reoperation; Survival Rate	1994
Effects of protein kinase C inhibitor, staurosporine derivative CGP 41 251, on cell cycle, DNA synthesis and drug uptake in neoplastic cell lines. Anti-cancer drugs, 1995, Volume: 6, Issue:1 Topics: Alkaloids; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Cycle; Cytarabine; DNA Replication; DNA, Neoplasm; Drug Resistance, Multiple; Drug Synergism; Female; Humans; Leukemia L1210; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred DBA; Neoplasm Proteins; Ovarian Neoplasms; Protein Kinase C; Staurosporine; Tumor Cells, Cultured	1995
Long-term follow-up of patients with epithelial carcinoma of the ovary. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1994, Volume: 44, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Mitomycin; Ovarian Neoplasms; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome	1994
Salvage intraperitoneal therapy of advanced epithelial ovarian cancer: impact of retroperitoneal nodal disease. European journal of gynaecological oncology, 1997, Volume: 18, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinoma; Cisplatin; Combined Modality Therapy; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Laparotomy; Lymphatic Metastasis; Middle Aged; Mitoxantrone; Neoplasm Staging; Ovarian Neoplasms; Retroperitoneal Space; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome	1997
Cell-cycle-dependent turnover of P-glycoprotein in multidrug-resistant cells. Journal of cellular physiology, 2000, Volume: 184, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Division; CHO Cells; Cisplatin; Colchicine; Cricetinae; Culture Media, Serum-Free; Cytarabine; Drug Resistance, Multiple; Female; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Ovarian Neoplasms; Tumor Cells, Cultured; Vinblastine; Vincristine	2000
Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer. Archives of gynecology and obstetrics, 2000, Volume: 263, Issue:4 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Mucinous; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Liver Neoplasms; Middle Aged; Mitoxantrone; Ovarian Neoplasms; Prednisolone; Remission Induction; Reoperation	2000
Primary granulocytic sarcoma of the ovary. American journal of clinical oncology, 2000, Volume: 23, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid; Ovarian Neoplasms; Remission Induction	2000
Effects of thymidine analogs upon growth control in cultured hormone-dependent ray ovary cells. Experimental cell research, 1975, Volume: 92, Issue:1 Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Culture Media; Cytarabine; Deoxyuridine; DNA; Female; Floxuridine; Hormones; Hydroxyurea; Idoxuridine; Kinetics; Ovarian Neoplasms; Rats; Thymidine	1975
Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer treatment reports, 1978, Volume: 62, Issue:1 Topics: Antineoplastic Agents; Ascitic Fluid; Cytarabine; Female; Humans; Injections, Intraperitoneal; Methotrexate; Models, Biological; Ovarian Neoplasms; Tissue Distribution	1978
Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol. The British journal of cancer. Supplement, 1975, Volume: 2 Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Lymph Nodes; Lymphoma; Male; Mediastinal Neoplasms; Methotrexate; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Skin Neoplasms; Stomach Neoplasms; Thioguanine; Vincristine	1975
Survival with intraperitoneal cisplatin in advanced ovarian cancer after second-look laparotomy. American journal of clinical oncology, 1992, Volume: 15, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Female; Humans; Infusions, Parenteral; Ovarian Neoplasms; Reoperation; Survival Analysis	1992
Leukemia following cisplatin-based chemotherapy for ovarian carcinoma at Roswell Park. European journal of gynaecological oncology, 1992, Volume: 13, Issue:2 Topics: Adult; Carcinoma, Papillary; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Thrombocytopenia	1992
Deoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells. Gynecologic oncology, 1992, Volume: 45, Issue:1 Topics: Antimetabolites, Antineoplastic; Blotting, Western; Bone Marrow Cells; Cisplatin; Cystadenocarcinoma; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Glutathione Transferase; Humans; Injections, Intraperitoneal; Injections, Intravenous; Ovarian Neoplasms; RNA, Messenger; Stem Cells; Tumor Cells, Cultured	1992
Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy. Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:2 Topics: Abdomen; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Infusions, Parenteral; Laparotomy; Mitoxantrone; Ovarian Neoplasms; Retrospective Studies; Tissue Adhesions	1992
[Results of intraperitoneal chemotherapy of ovarian cancer]. Journal de gynecologie, obstetrique et biologie de la reproduction, 1991, Volume: 20, Issue:3 Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Cytarabine; Female; Humans; Infusions, Parenteral; Mitoxantrone; Ovarian Neoplasms; Survival Rate	1991
Inhibition of DNA repair and the enhancement of cytotoxicity of alkylating agents. International journal of cancer, 1991, Jul-30, Volume: 48, Issue:6 Topics: Alkylating Agents; Antineoplastic Agents; Aphidicolin; Cell Line; Cell Survival; Cisplatin; Cytarabine; Diterpenes; DNA Damage; DNA Repair; Female; Humans; Lung Neoplasms; Melphalan; Nucleic Acid Synthesis Inhibitors; Ovarian Neoplasms; Thiotepa	1991
Burkitt's lymphoma in a 45-year-old Nigerian woman. Tropical and geographical medicine, 1990, Volume: 42, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Female; Humans; Middle Aged; Ovarian Neoplasms; Vincristine	1990
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside. Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:6 Topics: Adult; Aged; Arabinofuranosyluracil; Ascitic Fluid; Colonic Neoplasms; Cytarabine; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Leukopenia; Metabolic Clearance Rate; Middle Aged; Ovarian Neoplasms; Peritonitis; Thrombocytopenia; Time Factors	1990
Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. Gynecologic oncology, 1990, Volume: 37, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Staging; Ovarian Neoplasms	1990
First experiences with intraperitoneal chemotherapy in ovarian cancer. European journal of gynaecological oncology, 1990, Volume: 11, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Female; Humans; Infusions, Parenteral; Interferon Type I; Mitoxantrone; Ovarian Neoplasms; Peritoneal Cavity; Prognosis	1990
Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescence. Gynecologic oncology, 1990, Volume: 38, Issue:2 Topics: Adenosine Triphosphate; Antineoplastic Agents; Cell Line; Cisplatin; Cytarabine; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; In Vitro Techniques; Luminescent Measurements; Mitomycins; Ovarian Neoplasms; Vincristine	1990
[Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosyluracil; Carcinoma, Squamous Cell; Child; Cisplatin; Cystadenocarcinoma; Cytarabine; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusion Pumps; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Teratoma	1990
[A case of amylase-producing ovarian tumor]. Gan no rinsho. Japan journal of cancer clinics, 1986, Volume: 32, Issue:1 Topics: Amylases; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma; Cytarabine; Female; Fluorouracil; Humans; Hysterectomy; Middle Aged; Mitomycin; Mitomycins; Ovarian Neoplasms	1986
Fertility after chemotherapy for ovarian germ cell tumours. British journal of obstetrics and gynaecology, 1987, Volume: 94, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Fertility; Humans; Menstruation; Methotrexate; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Vincristine	1987
Fertility after chemotherapy for male and female germ cell tumours. International journal of andrology, 1987, Volume: 10, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Fertility; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Menstruation; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Spermatogenesis; Testicular Neoplasms; Vincristine	1987
Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:10 Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cytarabine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Risk	1987
[Changes in CA125 concentration in ovarian cancer patients during the remission state--mean attenuating curve and the effectiveness of surgery and chemotherapy]. Nihon Sanka Fujinka Gakkai zasshi, 1989, Volume: 41, Issue:5 Topics: Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Female; Fluorouracil; Half-Life; Humans; Mitomycin; Mitomycins; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Peptichemio; Remission Induction; Vinblastine; Vincristine	1989
[An analysis of factors influential in improving the survival rate of patients with ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Mitomycins; Ovarian Neoplasms; Peptichemio; Prognosis; Reoperation; Statistics as Topic	1989
Synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer model. Obstetrics and gynecology, 1989, Volume: 74, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Mice; Mice, Inbred C3H; Ovarian Neoplasms; Teratoma	1989
Transport and metabolism of 1-beta-D-arabinofuranosylcytosine in human ovarian adenocarcinoma cells. Cancer research, 1989, Jan-15, Volume: 49, Issue:2 Topics: Adenocarcinoma; Aged; Arabinofuranosylcytosine Triphosphate; Binding Sites; Cell Line; Cytarabine; Female; Humans; Leukemia, Myelomonocytic, Acute; Male; Ovarian Neoplasms; Thioinosine	1989
Synergistic effects of cis-platinum and cytosine arabinoside on ovarian carcinoma cell lines, demonstrated by dual-parameter flow cytometry. Gynecologic oncology, 1989, Volume: 32, Issue:3 Topics: Cell Count; Cell Cycle; Cell Line; Cell Survival; Cisplatin; Cytarabine; DNA, Neoplasm; Drug Synergism; Female; Flow Cytometry; Humans; Neoplasm Proteins; Ovarian Neoplasms	1989
[Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine after intraperitoneal administration]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:10 Topics: Aged; Antineoplastic Agents; Ascitic Fluid; Cystadenocarcinoma; Cytarabine; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritonitis; Uterine Neoplasms	1988
Resolution of malignant ascites after intraperitoneal chemotherapy in women with carcinoma of the ovary. Surgery, gynecology & obstetrics, 1988, Volume: 166, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma; Cisplatin; Cystadenocarcinoma; Cytarabine; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms	1988
The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: an update. Seminars in oncology, 1987, Volume: 14, Issue:2 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cytarabine; Female; Humans; Injections, Intraperitoneal; Ovarian Neoplasms	1987
Intraperitoneal chemotherapy: introduction into a community hospital. Progress in clinical and biological research, 1986, Volume: 216 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Cytarabine; Female; Humans; Ovarian Neoplasms	1986
Nursing procedures for intraperitoneal administration of cis-platin and Ara-C in the community hospital. Progress in clinical and biological research, 1986, Volume: 216 Topics: Adenocarcinoma; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms	1986
In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration. Seminars in oncology, 1985, Volume: 12, Issue:3 Suppl 4 Topics: Anthraquinones; Antineoplastic Agents; Cisplatin; Colony-Forming Units Assay; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Parenteral; Melphalan; Mitomycin; Mitomycins; Mitoxantrone; Ovarian Neoplasms; Peritoneal Cavity; Tumor Stem Cell Assay	1985
Lack of synergy between cisplatin and cytarabine against ovarian carcinoma in vitro. Cancer treatment reports, 1986, Volume: 70, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Survival; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Ovarian Neoplasms; Time Factors	1986
Melphalan and cytarabine administered intraperitoneally as single agents and combination intraperitoneal chemotherapy with cisplatin and cytarabine. Seminars in oncology, 1985, Volume: 12, Issue:3 Suppl 4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Digestive System Neoplasms; Doxorubicin; Drug Evaluation; Female; Humans; Infusions, Parenteral; Male; Melphalan; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity	1985
[Effects of chemotherapy of advanced malignant ovarian tumors]. Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Mitomycins; Ovarian Neoplasms; Prognosis	1985
[The effects of cytostatic agents on short-term cultures (3H-uridine incorporation) and tissue cultures (cell counts) from human tumors (author's transl)]. Archiv fur Gynakologie, 1974, May-14, Volume: 216, Issue:3 Topics: Antineoplastic Agents; Bleomycin; Cell Count; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Female; Fluorouracil; Humans; In Vitro Techniques; Methods; Methotrexate; Neoplasms; Ovarian Neoplasms; Podophyllin; Suspensions; Time Factors; Triaziquone; Tritium; Uridine	1974
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors. Cancer chemotherapy reports, 1972, Volume: 56, Issue:6 Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Cystadenoma; Cytarabine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Nausea; Neoplasm Metastasis; Neoplasms; Nitrosourea Compounds; Ovarian Neoplasms; Stomach Neoplasms; Vomiting	1972
Cell cycle changes in ovarian cancer after arabinosylcytosine. Cancer, 1974, Volume: 33, Issue:1 Topics: Adenocarcinoma; Ascites; Ascitic Fluid; Autoradiography; Cell Count; Cell Division; Cell Nucleus; Cell Survival; Cytarabine; Female; Glucose; Humans; Karyotyping; Kinetics; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms	1974